Jimmy Rosen serves as READDI’s chief executive officer and a member of the Board of Directors. He has 35 years of research, finance and operational experience across the healthcare and life sciences sectors. Jimmy is focused on developing medicines and products that are affordable and accessible to everyone who needs them, including underserved communities and those living in remote geographies.
Prior to READDI, Jimmy served as CEO of Artizan Biosciences, a biotech spinout from Yale University whose mission is creating new classes of precision therapeutics that target and block the root causes of chronic inflammatory disease. In previous roles, he was deputy director of venture investing at the Bill & Melinda Gates Foundation and a partner with Intersouth Partners, investing in early-stage life science companies. Earlier in his career he worked in health care research at Duke University, UNC-Chapel Hill and the National Cancer Institute and managed clinical trials for a private clinical research organization.
Jimmy has a Master of Business Administration from UNC Kenan-Flagler Business School and a Master of Science in Public Health from UNC Gillings School of Global Public Health, as well as a Bachelor of Arts in public policy from Duke University.